Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (NCT07357766) titled 'A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight' on Jan. 21.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Novo Nordisk A/S
Condition:
Overweight
Obesity
Intervention:
Drug: Cagrisema
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: June 9, 2026
Target Sample Size: 1400
Countries of Recruitment:
United States
Bulgaria
Denmark...